COLLEGIUM PHARMACEUTICAL, INC (COLL) Net margin 2016–2025
COLLEGIUM PHARMACEUTICAL, INC (COLL) net profit margin by fiscal year — reported net income divided by reported revenue.
8.1%FY2025 · since FY2016: -5504.1% → 8.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 8.1% | -2.9 pp |
| FY2024 | 10.9% | +2.5 pp |
| FY2023 | 8.5% | +13.9 pp |
| FY2022 | -5.4% | -31.4 pp |
| FY2021 | 26.0% | +17.4 pp |
| FY2020 | 8.6% | +16.3 pp |
| FY2019 | -7.7% | +6.3 pp |
| FY2018 | -14.0% | +249.0 pp |
| FY2017 | -262.9% | +5241.2 pp |
| FY2016 | -5504.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice